Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03915184
Title Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Carsgen Therapeutics, Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Mayo Clinic Hospital Phoenix Arizona 85054 United States Details
UCSF San Francisco California 94143 United States Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Dana Farber Cancer Center Boston Massachusetts 02215 United States Details
Mayo Rochester Minnesota 55905 United States Details
TriStar CMC Nashville Tennessee 37203 United States Details
UT Southwestern Medical Center Dallas Texas 76021 United States Details
MD Anderson Houston Texas 77030 United States Details
Methodist Hosptial Houston Texas 77030 United States Details
Huntsman Cancer Center Salt Lake City Utah 84112 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Princess Margaret Hospital Toronto Ontario MSG 2C4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field